International Journal of Clinical Research

Objective To study the clinical efficacy of Wang Bi tablet in the treatment of osteoarthritis of the knee. Methods: a total of 60 patients with osteoarthritis of the knee, who were treated in our hospital from January 2020 to December 2020, were 2021 into study group and control group. The patients in the control group were treated with diclofenac sustained-release tablets, while the patients in the research group were treated with Wang Bi tablets in addition to the control group. The clinical efficacy of the two groups was compared. Results: the total effective rate of the study group was higher than that of the control group, the scores of symptoms and signs of the study group were lower than those of the control group after treatment, the clinical correlation index was better than that of the control group, the score of quality of life was higher than that of the control group, the difference was significant (p < 0.05) . There were no obvious adverse reactions in both groups. Conclusion: Wang Bi Tablet is effective in the treatment of knee joint, it can effectively relieve the clinical symptoms, regulate the level of serum inflammatory factors, delay the development of the disease, and has a high safety, can help patients improve the quality of life.

Wang Bi tablets; diclofenac sustained-release tablets; knee osteoarthritis; clinical efficacy; safety